-- 根据周三提交给香港交易所的文件,杭州迪安生物科技有限公司(HKG:2526)预计2025年将亏损6710万元人民币,较上年同期的4340万元人民币亏损扩大。 这家医疗影像产品制造商的股价在周四下午的交易中上涨近3%。 每股亏损为0.84元人民币,而2024年预计为0.55元人民币。 营收同比增长超过一倍,从7040万元人民币增至1.644亿元人民币。
Related Articles
Prudential Buys Back Shares
Prudential (SGX:K6S, HKG:2378) bought back 635,107 shares in London on Wednesday at an average price of about 11.05 pounds sterling apiece, according to a Thursday Hong Kong bourse filing.The insurer intends to cancel the repurchased shares.Following the transaction, the company will have about 2.52 billion shares in issue.
Jiadeli Electronics Material Launches Shanghai IPO
Quanzhou Jiadeli Electronics Material (SHA:603435) launched its initial public offering of up to 46 million shares on the Shanghai Stock Exchange on Thursday, according to a bourse filing.The maker of biaxially oriented polypropylene or BOPP electrical films will have 459,167,540 shares after the IPO.GF Securities is the lead underwriter of the offering.
Market Chatter: Australian Data Center AirTrunk to Inject Further MYR Billion in Malaysia
Australia's AirTrunk will raise its investment in Malaysia by an additional 12 billion ringgit this year, lifting its total committed investment to 27 billion ringgit, The Star reported Wednesday, citing Prime Minister Anwar Ibrahim.The announcement followed a courtesy visit on Wednesday by AirTrunk founder and CEO Robin Khuda and his delegation, where discussions focused on ongoing data centre developments in Johor, Malaysia.Talks also covered a localization framework to expand participation of Malaysian firms in the data centre value chain, reportedly.Anwar said the commitment shows strong investor confidence in Malaysia as a regional digital hub, supported by continued policy improvements and streamlined approvals, the news outlet said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)